Claversal is a medication that belongs to the class of drugs known as aminosalicylates. It is primarily used for the treatment of inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease.
The active ingredient in Claversal is mesalazine, also known as 5-aminosalicylic acid (5-ASA). Mesalazine works by reducing the inflammation in the lining of the intestines, alleviating the symptoms associated with IBD.
Claversal is available in various forms, including tablets, suppositories, and rectal foam. The choice of formulation depends on the location and severity of the inflammation within the gastrointestinal tract.
When taken orally, Claversal tablets are usually swallowed whole with water, ensuring that they are not crushed or chewed. The medication can be taken with or without food, as directed by a healthcare professional.
The suppository form of Claversal is administered rectally to target inflammation in the lower part of the digestive system. It is important to follow the instructions provided, which usually involve inserting the suppository into the rectum and allowing it to dissolve.
Claversal may cause side effects, such as nausea, abdominal pain, headache, and diarrhea. It is essential to inform a healthcare provider if these side effects persist or worsen.
Overall, Claversal is a medication commonly prescribed for the management of IBD, providing relief from inflammation and its associated symptoms. It is important to follow the recommended dosage, use the appropriate formulation, and regularly communicate with a healthcare professional for optimal treatment outcomes.
